The University of Chicago Header Logo

Connection

Nishant Agrawal to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications Nishant Agrawal has written about Maximum Tolerated Dose.
Nishant Agrawal
Connection Strength
0.051
Maximum Tolerated Dose
  1. Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma. Br J Cancer. 2022 11; 127(8):1497-1506.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.